CPT code 93024 is billed for an ergonovine provocation test used to evaluate for coronary artery spasm by administering ergonovine and monitoring for chest pain and electrocardiographic changes. This diagnostic cardiac procedure has clinical importance for identifying vasospastic angina, guiding management, and informing downstream care decisions. Nationally, the code is relevant to hospital-based cardiology services and ambulatory cardiac catheterization centers that perform invasive or monitored diagnostic testing.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for the test, the typical sites of service, and payer coverage considerations. The publication also summarizes available benchmarks, coding and billing considerations, and recent policy updates that affect reimbursement and documentation requirements. Clinical implications for patient selection and test interpretation are provided to clarify when the procedure is clinically indicated.

This summary is intended for a national audience of clinicians, coding professionals, and policy analysts seeking a clear, practical briefing on CPT code 93024 and its role in diagnostic cardiovascular care.